What is the normal range for antinuclear antibodies? No. ANAs can be found in approximately 5% of the normal population, usually in low titers (low levels). These people usually have no disease. Titers of 1:80 or lower are less likely to be significant. (ANA titers of less than or ...
(2) underwent a liver biopsy consistent with CHC within 6 months of entering the study; and (3) displayed elevated serum alanine aminotransferase (ALT) levels, defined as ≥1.5 times the upper limit of the normal range for at least two measurements within the 6 months preceding the trial ...
doi:10.1681/ASN.20223311S1494cHema BalinaEdva NoelRizwan RabbaniIris J. LeeChristine P. BastlAmerican Society of NephrologyJournal of the American Society of Nephrology
Therefore it is also important to know the prevalence of in normal children. The main objective of the present study was to determine the prevalence of antinuclear antibody () in healthy children. Ninety-nine serum samples from a serum bank and 108 samples from patients who had attended ...
Rothfield NF, Stollar BD: The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest. 1967, 46: 1785-1794. Article PubMed Central CAS PubMed Google Scholar Hahn BH: Ant...
Of the children with chronic ITP, six (33%) of the children had at least one abnormal antibody value. Five children (16%) tested positive for ATA: 2 children with acute ITP and 3 with chronic ITP. Five children had positive ANA, and of these children, 4 (80%) had chronic ITP. ...
However, the possibility that antibody production is a spontaneous consequence of tumoral antigenicity, independent of ICI treatment, cannot be completely ruled out. We did not find differences in irAE prevalence between patients with and without pre-existing ANAs nor between patients with and without ...
ANA: antinuclear antibody. (B) ESSDAI score at diagnosis according to the ANA profile. The ESSDAI score is statistically higher at diagnosis in anti-Ro/SSA-positive patients compared to ANA-negative (KWT, p≤ 0.001) and non-identified ANA (KWT, p≤ 0.01) patients. Data are depicted as a...